Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Kay

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2006
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Katsuya Inagaki, Sally Fuess, Theresa A Storm, et al.
Human Gene Therapy|May 30, 2008
Good news on the clinical gene transfer frontJames M Wilson, Bernd Gansbacher, Kenneth I Berns, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8Bassel Akache, Dirk Grimm, Xuan Shen, et al.
The Journal of Clinical Investigation|August 11, 2010
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liverDirk Grimm, Lora Wang, Joyce S Lee, et al.
The Journal of Clinical Investigation|November 23, 2011
Fate tracing of mature hepatocytes in mouse liver homeostasis and regenerationYann Malato, Syed Naqvi, Nina Schürmann, et al.
Epigenetics & Chromatin|July 3, 2010
An in vitro-identified high-affinity nucleosome-positioning signal is capable of transiently positioning a nucleosome in vivoLia E Gracey, Zhi-Ying Chen, Jay M Maniar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Determinants of hepatitis C translational initiation in vitro, in cultured cells and miceAnton P McCaffrey, Kazuo Ohashi, Leonard Meuse, et al.
Journal of Virology|September 20, 2002
A prenylation inhibitor prevents production of infectious hepatitis delta virus particlesBruno B Bordier, Patricia L Marion, Kazuo Ohashi, et al.
Nature Communications|December 16, 2018
miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repressionPaul N Valdmanis, Hak Kyun Kim, Kirk Chu, et al.
Nature Methods|March 3, 2023
A standardized ontology for naming tRNA-derived RNAs based on molecular originAndrew D Holmes, Patricia P Chan, Qi Chen, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2006
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Katsuya Inagaki, Sally Fuess, Theresa A Storm, et al.
Human Gene Therapy|May 30, 2008
Good news on the clinical gene transfer frontJames M Wilson, Bernd Gansbacher, Kenneth I Berns, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8Bassel Akache, Dirk Grimm, Xuan Shen, et al.
The Journal of Clinical Investigation|August 11, 2010
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liverDirk Grimm, Lora Wang, Joyce S Lee, et al.
The Journal of Clinical Investigation|November 23, 2011
Fate tracing of mature hepatocytes in mouse liver homeostasis and regenerationYann Malato, Syed Naqvi, Nina Schürmann, et al.
Epigenetics & Chromatin|July 3, 2010
An in vitro-identified high-affinity nucleosome-positioning signal is capable of transiently positioning a nucleosome in vivoLia E Gracey, Zhi-Ying Chen, Jay M Maniar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Determinants of hepatitis C translational initiation in vitro, in cultured cells and miceAnton P McCaffrey, Kazuo Ohashi, Leonard Meuse, et al.
Journal of Virology|September 20, 2002
A prenylation inhibitor prevents production of infectious hepatitis delta virus particlesBruno B Bordier, Patricia L Marion, Kazuo Ohashi, et al.
Nature Communications|December 16, 2018
miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repressionPaul N Valdmanis, Hak Kyun Kim, Kirk Chu, et al.
Nature Methods|March 3, 2023
A standardized ontology for naming tRNA-derived RNAs based on molecular originAndrew D Holmes, Patricia P Chan, Qi Chen, et al.
Pageof 20